• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » BaroNova launches TPS weight-loss trial

BaroNova launches TPS weight-loss trial

December 11, 2015 By Fink Densford

BAROnova

BaroNova said today it enrolled the 1st 4 patients in its ENDObesity II study pivotal clinical trial to test its TransPyloric Shuttle designed to treat obesity.

The TransPyloric Shuttle is inserted and removed through the mouth endoscopically to slow gastric emptying and encourage weight loss, the company said. In a feasibility study, patients with BMIs of 30-40 kg/m2 reported average excess weight loss of 58% after 6 months.

“This study will contribute significantly to the understanding of endoscopic therapies for the management of obesity, which has continued to rise as a major health challenge. Our patients need alternatives to invasive bariatric surgical procedures. The TPS showed great promise in its initial feasibility study and we are enthusiastic to begin the pivotal trial at this time,” lead investigator Dr. Richard Rothstein of Hanover, N.H.’s Geisel School of Medicine at Dartmouth said in a prepared statement.

The 12-month, multicenter pivotal clinical trial is slated enroll 270 patients at up to 12 sites in the U.S.

“Initiation of this pivotal trial is an important milestone for the company and is the first step on the path to provide a less-invasive, removable, low-cost medical device to combat obesity,” CEO Hugh Narciso said in a press release.

Goleta, Calif.-based BaroNova said it hopes to use results from the trial to support an FDA application for regulatory approval and future commercialization of the device.

“With over 35% of adults and 17% of children classified as obese in the United States, we are committed to bringing this innovative technology to patients in need,” clinical affairs veep Dr. Lian Cunningham said in prepared remarks.

“We successfully enrolled and did procedures on the first four participants in the ENDObesity II Study. We are looking forward to enrolling more participants at our site and ultimately evaluating the effects of the TransPyloric Shuttle at 12 months,” Dr. Shelby Sullivan of St. Louis, Mo.’s Washington University School of Medicine said in a press release.

Filed Under: Clinical Trials, Weight loss Tagged With: BaroNova

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy